You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 23, 2025

Drug Price Trends for ZADITOR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ZADITOR

Best Wholesale Price for ZADITOR

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
ZADITOR OPHTHALMIC SOLUTION 0.025% Alcon Vision, LLC 00065-4011-05 5ML 9.61 1.92200 ML 2020-09-24 - 2025-09-23 FSS
ZADITOR OPHTHALMIC SOLUTION 0.025% Alcon Vision, LLC 00065-4011-06 2X5ML 16.01 2020-09-24 - 2025-09-23 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Zaditor

Overview of Zaditor

Zaditor, also known as ketotifen ophthalmic solution, is an antihistamine and decongestant used to treat allergic conjunctivitis. It is part of the broader ophthalmic drugs market, which is experiencing significant growth due to increasing prevalence of eye disorders.

Global Ophthalmic Drugs Market

The global ophthalmic drugs market is projected to grow substantially in the coming years. According to market analyses, the global ophthalmic drugs market is expected to reach around USD 67.1 billion by 2030, growing at a CAGR of 7.40% from 2022 to 2030[1][4].

Market Segments and Growth Drivers

The prescription drugs segment, which includes Zaditor, held the largest revenue share of 60.1% in 2021 and is expected to maintain its dominance throughout the forecast period. The growth in this segment is driven by the rising prevalence of disorders such as age-related macular degeneration (AMD) and diabetic retinopathy. Improved efficacy and better safety profiles of prescription drugs are also key factors contributing to their demand[1].

Regional Market Analysis

North America is the largest market for ophthalmic drugs, driven by increased prevalence of eye illnesses and growing public awareness of eye ailments. This region is expected to grow at a CAGR of 6.7% during the forecast period. The Asia-Pacific region, however, is the fastest-growing market, with a CAGR of 5.65%, due to a large patient pool, high disease prevalence, and the rise of local pharmaceutical companies[4].

Pricing and Cost Considerations for Zaditor

The cost for Zaditor 0.025% ophthalmic solution is around $20 for a supply of 5 milliliters, depending on the pharmacy. Generic versions of Zaditor are also available, which can be slightly cheaper, starting from $20.97 for 5 milliliters[2].

Patient Assistance and Copay Programs

To make Zaditor more accessible, patient assistance programs (PAPs) and copay cards are available. For example, the Rx Outreach Medications program offers Zaditor for a fee of $20 for up to a 180-day supply, subject to eligibility criteria. Additionally, the Drugs.com Discount Card can save consumers up to 80% on the cost of Zaditor and other prescription medicines[2].

Market Trends and Competitive Landscape

The ophthalmic drugs market is highly competitive, with notable players such as Bausch and Lomb, Pfizer Inc., and Alcon. Strategic actions by these companies, including new product launches and commercial sales, are expected to drive market growth. For instance, Harrow Health Inc. announced the commercial sale of MAXITROL and IOPIDINE 1% in the United States, which is expected to contribute to the regional market growth[4].

Price Projections

Given the overall growth of the ophthalmic drugs market, the demand for Zaditor is likely to increase. However, the price of Zaditor may remain relatively stable due to the availability of generic versions and patient assistance programs. Here are some key points to consider:

  • Current Pricing: The current price for Zaditor is around $20 for a 5-milliliter supply.
  • Generic Availability: Generic versions are available at slightly lower prices.
  • Patient Assistance: Programs like Rx Outreach and discount cards can significantly reduce out-of-pocket costs.
  • Market Growth: The growing demand for ophthalmic drugs could lead to slight price increases, but competition and generic options are likely to keep prices in check.

Key Takeaways

  • The global ophthalmic drugs market is expected to reach USD 67.1 billion by 2030.
  • The prescription drugs segment, including Zaditor, dominates the market.
  • North America is the largest market, while the Asia-Pacific region is the fastest-growing.
  • Zaditor pricing is around $20 for a 5-milliliter supply, with generic options available.
  • Patient assistance programs and discount cards can reduce costs.

FAQs

Q: What is the current market size of the global ophthalmic drugs market? A: The global ophthalmic drugs market was valued at USD 33.9 billion in 2021[1].

Q: What is the projected growth rate of the ophthalmic drugs market? A: The market is expected to grow at a CAGR of 7.40% from 2022 to 2030[1].

Q: What is the typical cost of Zaditor ophthalmic solution? A: The cost for Zaditor 0.025% ophthalmic solution is around $20 for a supply of 5 milliliters[2].

Q: Are there any patient assistance programs available for Zaditor? A: Yes, programs like Rx Outreach and discount cards from Drugs.com can help reduce the cost of Zaditor[2].

Q: Which region is expected to be the fastest-growing market for ophthalmic drugs? A: The Asia-Pacific region is expected to be the fastest-growing market, driven by a large patient pool and high disease prevalence[4].

Sources

  1. Nova One Advisor: Ophthalmic Drugs Market Demand and Growth Analysis with Forecast up to 2030.
  2. Drugs.com: Zaditor Prices, Coupons, Copay Cards & Patient Assistance.
  3. FDA: Nonprescription Drug Product with an Additional Condition for Safe Use.
  4. Straits Research: Ophthalmic Drugs Market Size to Grow at a CAGR of 7.4% by 2030.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.